Concepedia

Maaike van Dartel

MV

13

Publications

379

Citations

11

H-Index

2001

Active since

Affiliations

Medicines Evaluation Board(Current)

Dutch Institute for Clinical Auditing

Rode Kruis Ziekenhuis

University Medical Center Groningen

Leiden University Medical Center

Maaike van Dartel is an author at Medicines Evaluation Board specializing in medicine, cancer research, and pathology.

ORCID

Top concepts

Publications per year

2001–2022

13

Publications

13

Amplification of 17p11.2∼p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma

Maaike van Dartel, Peter W.A. Cornelissen, Sandra Redeker et al. · Cancer Genetics and Cytogenetics · 2002 · 69 citations

, , +6

Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer

Rawa K. Ismail, Jesper van Breeschoten, Michel W.J.M. Wouters et al. · The Breast · 2021 · 40 citations · Full text

Real‐world outcomes of advanced melanoma patients not represented in phase <scp>III</scp> trials

Michiel C.T. van Zeijl, Rawa K. Ismail, Liesbeth C. de Wreede et al. · International Journal of Cancer · 2020 · 36 citations · Full text

The Dutch Lung Cancer Audit: Nationwide quality of care evaluation of lung cancer patients

Rawa K. Ismail, Franz M.N.H. Schramel, Maaike van Dartel et al. · Lung Cancer · 2020 · 36 citations · Full text

Overexpression through amplification of genes in chromosome region 17p11.2∼p12 in high-grade osteosarcoma

Maaike van Dartel, Sandra Redeker, Johannes Bras et al. · Cancer Genetics and Cytogenetics · 2004 · 35 citations

, , +6

Rows per page

1–5 of 13